In the SUSTAIN 1-7 series of clinical trials which investigated the effectiveness of once weekly semaglutide injections for the treatment of diabetic and obese patients, semaglutide consistently demonstrated significant reductions in HbA1c levels compared to placebo and other usual diabetes medications (metformin, sitagliptin, dulaglutide)
Research indicates GLP-1 agonists do not impair thyroid hormone absorption or metabolism significantly
Knowing your plans rules upfront saves weeks of frustration and prevents treatment gaps
The article did not specify what counts as microdosing, but one mentioned dose was 0.05mg (1/5th of the 0.25mg starting dose for Wegovy) which corresponds to 2% of the final 2.4mg milligram dose that patients progress to after 5 months
Weight loss is a personal journey and can be impacted by several factors, including your starting weight, lifestyle changes, and side effects
Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers
